Group Introduction

[Its Dual-Listed Companies] Joincare Pharmaceutical Group (Stock Code: 600380 GDR Code:JCARE) Livzon Pharmaceutical Group (Stock Code: 000513 Hong Kong Stock Code: 01513)

Zhuhai Lizhu Reagent Co., Ltd.

LiZhu Reagent Co., Ltd. (hereinafter referred to as "LiZhu Reagent"), founded in 1989, is the first high-tech subsidiary of LiZhu Pharmaceutical Group (a listed company on the A-share and H-share markets). It specializes in the research, development, production, and marketing of in-vitro diagnostic reagents and related equipment. It is one of the earliest manufacturers of in-vitro diagnostic reagents in China and a national high-tech enterprise.


LiZhu Reagent has established numerous technical platforms, including enzyme-linked immunosorbent assay (ELISA), colloidal gold, microbiology, molecular detection, multiplex immunoassay, single-use chemiluminescence, fully automated POCT, and mast cell degranulation. It possesses strong multi-platform R&D capabilities and fully automated supporting equipment development technology. Products cover many fields, including infectious diseases, respiratory infections, tumor marker detection, drug concentration monitoring, autoimmunity, allergen detection, and blood safety. It holds a leading market share in respiratory infections, infectious diseases, and drug concentration monitoring in China, with many products achieving a market share of 50%-90%.


The company has built an industrial base integrating R&D, production, and offices, covering an area of over 23,000 square meters and a building area of over 44,000 square meters. The R&D area covers 6,000 square meters. It brings together professional elites from various fields, including clinical laboratory medicine and bioengineering. It has five R&D teams and three R&D centers located in Zhuhai, Shanghai, and Suzhou. R&D personnel account for nearly 20% of the workforce, and annual R&D investment exceeds 10% of sales revenue. While conducting independent research and development, LiZhu Reagent has established long-term and good cooperation with world-class biomedical companies such as Fujirebio (Japan), Siemens (Germany), and MP Biomedicals (USA), further enhancing the company's comprehensive service capabilities. The company has successively won the titles of "National High-tech Enterprise," "Guangdong Provincial Engineering Technology Research Center for In Vitro Diagnosis," "Guangdong Provincial Enterprise Technology Center," "Guangdong Provincial Innovative Enterprise," and the national "Postdoctoral Research Workstation." It also has a complete production quality management system and has passed national GMP certification, GSP certification, and ISO13485/ISO9001 certification.